These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 35183242)

  • 1. IMI2-PainCare-BioPain-RCT1: study protocol for a randomized, double-blind, placebo-controlled, crossover, multi-center trial in healthy subjects to investigate the effects of lacosamide, pregabalin, and tapentadol on biomarkers of pain processing observed by peripheral nerve excitability testing (NET).
    Nochi Z; Pia H; Bloms-Funke P; Boesl I; Caspani O; Chapman SC; Fardo F; Genser B; Goetz M; Kostenko AV; Leone C; Li T; Mouraux A; Pelz B; Pogatzki-Zahn E; Schilder A; Schnetter E; Schubart K; Stouffs A; Tracey I; Troconiz IF; Truini A; Van Niel J; Vela JM; Vincent K; Vollert J; Wanigasekera V; Wittayer M; Tankisi H; Finnerup NB; Phillips KG; Treede RD
    Trials; 2022 Feb; 23(1):163. PubMed ID: 35183242
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IMI2-PainCare-BioPain-RCT2 protocol: a randomized, double-blind, placebo-controlled, crossover, multicenter trial in healthy subjects to investigate the effects of lacosamide, pregabalin, and tapentadol on biomarkers of pain processing observed by non-invasive neurophysiological measurements of human spinal cord and brainstem activity.
    Leone C; Di Stefano G; Di Pietro G; Bloms-Funke P; Boesl I; Caspani O; Chapman SC; Finnerup NB; Garcia-Larrea L; Li T; Goetz M; Mouraux A; Pelz B; Pogatzki-Zahn E; Schilder A; Schnetter E; Schubart K; Tracey I; Troconiz IF; Van Niel H; Hernandez JMV; Vincent K; Vollert J; Wanigasekera V; Wittayer M; Phillips KG; Truini A; Treede RD
    Trials; 2022 Sep; 23(1):739. PubMed ID: 36064434
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IMI2-PainCare-BioPain-RCT3: a randomized, double-blind, placebo-controlled, crossover, multi-center trial in healthy subjects to investigate the effects of lacosamide, pregabalin, and tapentadol on biomarkers of pain processing observed by electroencephalography (EEG).
    Mouraux A; Bloms-Funke P; Boesl I; Caspani O; Chapman SC; Di Stefano G; Finnerup NB; Garcia-Larrea L; Goetz M; Kostenko A; Pelz B; Pogatzki-Zahn E; Schubart K; Stouffs A; Truini A; Tracey I; Troconiz IF; Van Niel J; Vela JM; Vincent K; Vollert J; Wanigasekera V; Wittayer M; Phillips KG; Treede RD
    Trials; 2021 Jun; 22(1):404. PubMed ID: 34140041
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of Mexiletine and Lacosamide on Nerve Excitability in Healthy Subjects: A Randomized, Double-Blind, Placebo-Controlled, Crossover Study.
    Ruijs TQ; Koopmans IW; de Kam ML; van Esdonk MJ; Koltzenburg M; Groeneveld GJ; Heuberger JAAC
    Clin Pharmacol Ther; 2022 Nov; 112(5):1008-1019. PubMed ID: 35762293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigation of the predictive validity of laser-EPs in normal, UVB-inflamed and capsaicin-irritated skin with four analgesic compounds in healthy volunteers.
    Schaffler K; Nicolas LB; Borta A; Brand T; Reitmeir P; Roebling R; Scholpp J
    Br J Clin Pharmacol; 2017 Jul; 83(7):1424-1435. PubMed ID: 28139023
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of lacosamide in peripheral neuropathic pain: study protocol for a randomized, placebo-controlled, phenotype-stratified trial.
    Carmland ME; Kreutzfeldt M; Holbech JV; Andersen NT; Jensen TS; Bach FW; Sindrup SH; Finnerup NB
    Trials; 2019 Oct; 20(1):588. PubMed ID: 31604475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy, safety, and tolerability of lacosamide in patients with gain-of-function Nav1.7 mutation-related small fiber neuropathy: study protocol of a randomized controlled trial-the LENSS study.
    de Greef BT; Merkies IS; Geerts M; Faber CG; Hoeijmakers JG
    Trials; 2016 Jun; 17(1):306. PubMed ID: 27363506
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pregabalin versus placebo in targeting pro-nociceptive mechanisms to prevent chronic pain after whiplash injury in at-risk individuals - a feasibility study for a randomised controlled trial.
    Nikles J; Keijzers G; Mitchell G; Schug S; Ware R; McLean SA; Connelly L; Gibson S; Farrell SF; Sterling M
    Trials; 2018 Jan; 19(1):44. PubMed ID: 29343280
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multicentre, double-blind, crossover trial to identify the Optimal Pathway for TreatIng neurOpathic paiN in Diabetes Mellitus (OPTION-DM): study protocol for a randomised controlled trial.
    Selvarajah D; Petrie J; White D; Julious S; Bortolami O; Cooper C; Bradburn M; Loban A; Bowler H; Swaby L; Sutherland K; Tesfaye S;
    Trials; 2018 Oct; 19(1):578. PubMed ID: 30348206
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Examining the clinical utility of lacosamide: pooled analyses of three phase II/III clinical trials.
    Chung S; Ben-Menachem E; Sperling MR; Rosenfeld W; Fountain NB; Benbadis S; Hebert D; Isojärvi J; Doty P
    CNS Drugs; 2010 Dec; 24(12):1041-54. PubMed ID: 21090838
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of Ezogabine on Cortical and Spinal Motor Neuron Excitability in Amyotrophic Lateral Sclerosis: A Randomized Clinical Trial.
    Wainger BJ; Macklin EA; Vucic S; McIlduff CE; Paganoni S; Maragakis NJ; Bedlack R; Goyal NA; Rutkove SB; Lange DJ; Rivner MH; Goutman SA; Ladha SS; Mauricio EA; Baloh RH; Simmons Z; Pothier L; Kassis SB; La T; Hall M; Evora A; Klements D; Hurtado A; Pereira JD; Koh J; Celnik PA; Chaudhry V; Gable K; Juel VC; Phielipp N; Marei A; Rosenquist P; Meehan S; Oskarsson B; Lewis RA; Kaur D; Kiskinis E; Woolf CJ; Eggan K; Weiss MD; Berry JD; David WS; Davila-Perez P; Camprodon JA; Pascual-Leone A; Kiernan MC; Shefner JM; Atassi N; Cudkowicz ME
    JAMA Neurol; 2021 Feb; 78(2):186-196. PubMed ID: 33226425
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Strength-duration properties of sensory and motor axons in alcoholic polyneuropathy.
    Yerdelen D; Koc F; Uysal H
    Neurol Res; 2008 Sep; 30(7):746-50. PubMed ID: 18489821
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiepileptic drugs for chronic non-cancer pain in children and adolescents.
    Cooper TE; Wiffen PJ; Heathcote LC; Clinch J; Howard R; Krane E; Lord SM; Sethna N; Schechter N; Wood C
    Cochrane Database Syst Rev; 2017 Aug; 8(8):CD012536. PubMed ID: 28779491
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Altered excitability of small cutaneous nerve fibers during cooling assessed with the perception threshold tracking technique.
    Hugosdottir R; Mørch CD; Jørgensen CK; Nielsen CW; Olsen MV; Pedersen MJ; Tigerholm J
    BMC Neurosci; 2019 Sep; 20(1):47. PubMed ID: 31481024
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of lacosamide and carbamazepine on human motor cortex excitability: a double-blind, placebo-controlled transcranial magnetic stimulation study.
    Lang N; Rothkegel H; Peckolt H; Deuschl G
    Seizure; 2013 Nov; 22(9):726-30. PubMed ID: 23778157
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetic and pharmacodynamic properties of buprenorphine after a single intravenous administration in healthy volunteers: a randomized, double-blind, placebo-controlled, crossover study.
    Escher M; Daali Y; Chabert J; Hopfgartner G; Dayer P; Desmeules J
    Clin Ther; 2007 Aug; 29(8):1620-31. PubMed ID: 17919544
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness and Safety of Tapentadol Prolonged Release (PR) Versus a Combination of Tapentadol PR and Pregabalin for the Management of Severe, Chronic Low Back Pain With a Neuropathic Component: A Randomized, Double-blind, Phase 3b Study.
    Baron R; Martin-Mola E; Müller M; Dubois C; Falke D; Steigerwald I
    Pain Pract; 2015 Jun; 15(5):455-70. PubMed ID: 24738609
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of pregabalin 600 mg/d for treating painful diabetic peripheral neuropathy: a double-blind placebo-controlled trial.
    Arezzo JC; Rosenstock J; Lamoreaux L; Pauer L
    BMC Neurol; 2008 Sep; 8():33. PubMed ID: 18796160
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A new fully human recombinant FSH (follitropin epsilon): two phase I randomized placebo and comparator-controlled pharmacokinetic and pharmacodynamic trials.
    Abd-Elaziz K; Duijkers I; Stöckl L; Dietrich B; Klipping C; Eckert K; Goletz S
    Hum Reprod; 2017 Aug; 32(8):1639-1647. PubMed ID: 28591833
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.